Intravascular lymphoma presenting as a specific pulmonary embolism and acute respiratory failure: a case report by Georgin-Lavialle, Sophie et al.
Case report
Open Access
Intravascular lymphoma presenting as a specific pulmonary






1 and Elie Azoulay
1
Address:
1AP-HP, Hôpital Saint-Louis, Medical ICU, Department of Immunology and Department of Nuclear Médicine, 75010 Paris, France and
2Medical Intensive Care Unit, Saint-Louis University Hospital, 1 Avenue Claude Vellefaux, 75010 Paris, France
Email: SGL - sophiegeorgin@yahoo.fr; MD - michael.darmon@sls.aphp.fr; LG - lionel.galicier@sls.aphp.fr; MF - marinos.fysekidis@sls.aphp.fr;
EA - elie.azoulay@sls.aphp.fr
*Corresponding author
Published: 12 May 2009 Received: 18 July 2008
Accepted: 23 January 2009 Journal of Medical Case Reports 2009, 3:7253 doi: 10.1186/1752-1947-3-7253
This article is available from: http://jmedicalcasereports.com/jmedicalcasereports/article/view/7253
© 2009 Georgin-Lavialle et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: The occurrence of an intravascular lymphoma with severe pulmonary involvement
mimicking pulmonary embolism is described.
Case presentation: A 38-year-old man was referred to our intensive care unit with acute
respiratory failure and long lasting fever. Appropriate investigations failed to demonstrate any
bacterial, viral, parasitic or mycobacterial infection. A chest computed tomography scan ruled out any
proximal or sub-segmental pulmonary embolism but the ventilation/perfusion lung scan concluded
that there was a high probability of pulmonary embolism. The cutaneous biopsy pathology diagnosed
intravascular lymphoma.
Conclusion: Intravascular lymphoma is a rare disease characterized by exclusive or predominant
growth of neoplastic cells within the lumina of small blood vessels. Lung involvement seems to be
common, but predominant lung presentation of this disease is rare. In our patient, urgent
chemotherapy, along with adequate supportive care allowed complete recovery.
Introduction
Intravascular lymphoma (IVL) is an intravascular prolif-
eration of clonal lymphocytes with little to no parench-
ymal involvement. The clinical presentation is highly
variable, ranging from no or limited organ involvement to
multiple organ failure. Therefore, the diagnosis is often
difficult. Proliferation of lymphoma cells in blood vessels
of parenchymal organs results in vessel obliteration and
ischemia. We report a patient with an intravascular
lymphoma with predominant pulmonary involvement,
presenting as acute respiratory failure and a specific
pulmonary embolism.
Case presentation
In May 2005, a 38-year-old man was referred to our
intensive care unit with acute respiratory failure and long
lasting fever. He had an unremarkable medical history
until 5 months ago when he was referred for a 15 kg
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(page number not for citation purposes)weight loss and fever. Clinical examination was normal at
that time. Appropriate investigations failed to demonstrate
any bacterial, viral, parasitic or mycobacterial infection,
including intracellular bacteria, HIV, hepatitis B virus,
hepatitis C virus, tuberculosis, typhoid, syphilis, or
brucellosis. Antinuclear antibodies, rheumatoid factors,
and anti-neutrophil cytoplasmic antibodies were also
negative. No monoclonal immunoglobulin was detected
in serum or urine. Thoracic and abdominal computed
tomography (CT) scan revealed no abnormality except a
homogeneous splenomegaly. In April 2005, bone marrow
aspiration demonstrated evidence of hemophagocytosis
without any other abnormality and a lymphoproliferation
was therefore suspected. The bone marrow biopsy was
normal and diagnostic splenectomy was performed, but
the pathologic examination of the spleen was inconclu-
sive. Since there was a high suspicion of histiocytic
lymphohistiocytosis and of lymphoproliferation, steroids
were started leading to transient improvement in the
patient’s clinical condition.
In May 2005, the patient developed acute respiratory
failure, with profound hypoxemia of PaO2 35 mmHg
while breathing room air, and a shunt effect only partly
corrected by oxygen PaO2 51 mmHg and PaCO2
25 mmHg while under 5 L/minute O2. He was referred
to the ICU with a clinical diagnosis of highly probable
pulmonary embolism with acute right heart insufficiency.
In addition to persistent fever (39.3°C), clinical examina-
tion revealed an exanthema, as well as jugular venous
distension, without any other signs of cardiac failure.
The clinical examination was otherwise unremarkable.
Clinical andradiological examination showednoevidence
of pneumonia or bronchiolitis. Ultrasonography of the
deeplegveinswasnegative.Hishemoglobinlevelwas10.6
g/dL mean corpuscular volume, 94 fL; mean corpuscular
hemoglobin 31.2 pg, and platelet count was 117 g/L. The
peripheral blood picture was unremarkable and the serum
lactate dehydrogenase level was elevated at 1164 U/L.
A chest CT-scan ruled out any proximal or sub-segmental
pulmonary embolism but the ventilation/perfusion lung
scan indicated a high probability of pulmonary embolism
with multiple bilateral and distal perfusion defects with-
out evidence of a right-left shunt (Figure 1, left panel).
A cutaneous biopsy was performed, showing several
abnormal lymphocytes on cytological examination of
biopsy smears and suggesting lymphoma. The cutaneous
biopsy pathology revealed large pleomorphic cells expres-
sing CD20 in blood vessels and was diagnosed as
intravascular lymphoma (Figure 2).
Despite the acute respiratory failure and the profound
hypoxemia, non-invasive mechanical ventilation was not
performed mainly because of the acute right insufficiency.
The patient required no organ support other than oxygen
therapy.
Urgent cancer chemotherapy of cyclophosphamide, adria-
mycin, VP16 and steroids (CHOP) was started in order to
treat the malignant pulmonary vascular involvement. This
treatment led to a dramatic improvement in the patient’s
clinical condition. Five days after admission, he was free of
oxygen therapy and the perfusion lung scan was normal
(Figure 1, right panel). After six cycles of chemotherapy
with CHOP-Methotrexate associated with Rituximab, the
patient was considered to be in complete remission (CR).
High-dose chemotherapy with autologous stem cell
transplantation was carried out. The patient was alive in
CR at 1 June 2008.
Discussion
Intravascular large B-cell lymphoma is a rare disease
characterized by exclusive or predominant growth of
neoplastic cells within the lumina of small blood vessels
[1]. Proliferation of lymphoma cells in blood vessels of
parenchymal organs results in vessel obliteration and
ischemia. Less than half of patients have antemortem
diagnosis. Lung involvement seems to be common, but
predominant lung presentation of this disease is rare [2, 3].
Figure 1. Perfusion lung scan before (left panel) and after
(right panel) cancer chemotherapy.
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reported with pulmonary hypertension or suspicion of
pulmonary embolism [2, 4, 5]. Anthracycline-based che-
motherapy has been shown to be associated with a nearly
60% response rate and a 3-year overall survival rate higher
than 30%. Therefore CHOP and CHOP-like regimens are
consideredtobeefficient[6].Feverofunknownoriginisthe
presentingfeaturein60%ofintravascularlymphomaandis
frequently associated with a hemophagocytic lymphohis-
tiocytosis [6]. Although our patient did not meet all the
usual criteria for this syndrome, the clinical presentation of
bicytopenia, long lasting fever, and splenomegaly, along
with the typical image of hemophagocytosis at bone
marrow aspiration in this context allowed us to suspect
hemophagocytic lymphohistiocytosis and was therefore
highly suggestive of lymphoma [6, 7]. Pulmonary involve-
ment of hemophagocytic lymphohistiocytosis may occur in
up to 30% of patients but is usually associated with
pulmonary infiltrates [8]. The clinical course of the disease,
negativity of the extensive search for acute and chronic
pulmonary infection and the absence of pneumonia or
bronchiolitis allowed us to rule out an infectious disease.
Lastly, the high probability ventilation/perfusion lung scan
withanormalCT-scan,theabsenceofdeepveinthrombosis
alongwiththepresenceofabnormallymphocytesledtothe
diagnosis of non-thrombotic pulmonary embolism and to
initiate urgent cancer chemotherapy for malignant vascular
pulmonary involvement.
In patients with specific organ failure and a high suspicion
of active malignancy, urgent chemotherapy, along with
adequate supportive care is the only means of ensuring
recovery. In a recent series of selected patients, we report
about 50% survival in cancer patients with specific organ
failure and the need of immediate cancer chemotherapy
initiation, along with mechanical ventilation, vasopressors
and dialysis [9].
Conclusion
This case confirms that, although rare, intravascular
lymphoma may be responsible for precapillary pulmonary
arterial hypertension and may cause life-threatening
manifestationsrequiring urgent chemotherapy.Cutaneous
biopsy may provide a diagnosis and should be performed
on an emergency basis each time a diagnosis of intravas-
cular lymphoma is suspected. In the sickest patients with
life-threatening complications, the high suspicion of
malignancy along with the presence of abnormal cells
should prompt the clinician to initiate appropriate cancer
therapy before definite diagnosis in order to restore organ
function and increase the chances of survival.
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Figure 2. Cutaneous punch biopsy showing an intravascular
lymphocytic infiltrate (a) composed of large atypical cells (b) that
were CD20 positive on an immunohistochemical stain (c).
Page 3 of 4
(page number not for citation purposes)
Journal of Medical Case Reports 2009, 3:7253 http://jmedicalcasereports.com/jmedicalcasereports/article/view/7253images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MD and SGL acquired the data and drafted the manu-
script. EA critically revised the manuscript and supervised
the work. LG was the attending hematologist. The
perfusion lung-scan was performed by MF.
Acknowledgments
We thank O. Verola MD and V. Martinez MD, PhD for
providing images of the cutaneous biopsy and helping
with this manuscript.
References
1. Ferreri AJ, Campo E, Seymour JF, et al.: Intravascular lymphoma:
clinical presentation, natural history, management and
prognostic factors in a series of 38 cases, with special
emphasis on the ‘cutaneous variant’. Br J Haematol 2004,
127:173-183.
2. Aouba A, Diop S, Saadoun D, et al.: Severe pulmonary arterial
hypertension as initial manifestation of intravascular lym-
phoma: case report. Am J Hematol 2005, 79:46-49.
3. Wick MR, Mills SE, Scheithauer BW, et al.: Reassessment of
malignant “angioendotheliomatosis”. Evidence in favor of its
reclassification as “intravascular lymphomatosis”. Am J Surg
Pathol 1986, 10:112-123.
4. Owa M, Koyama J, Asakawa K, et al.: Intravascular lymphomatosis
presenting as reversible severe pulmonary hypertension. Int J
Cardiol 2000, 75:283-284.
5. Snyder LS, Harmon KR, Estensen RD: Intravascular lymphoma-
tosis (malignant angioendotheliomatosis) presenting as pul-
monary hypertension. Chest 1989, 96:1199-1200.
6. Ponzoni M, Ferreri AJ, Campo E, et al.: Definition, diagnosis, and
management of intravascular large B-cell lymphoma: pro-
posals and perspectives from an international consensus
meeting. J Clin Oncol 2007, 25:3168-3173.
7. Créput C, Galicier L, Buyse S, Azoulay E: Understanding organ
dysfunction in hemophagocytic lymphohistiocytosis. Intensive
Care Med 2008, 34(7):1177-1187.
8. Ohta H, Yumara-Yagi K, Sakata N, Inoue M, Kawa-Ha K: Capillary
leak syndrome in patients with hemophagocytic lymphohis-
tiocytosis. Acta Paediatr 1994, 83(10):1113-1114.
9. Darmon M, Thiery G, Ciroldi M, et al.: Intensive care in patients
with newly diagnosed malignancies and a need for cancer
chemotherapy. Crit Care Med 2005, 33(11):2488-2493.
Page 4 of 4
(page number not for citation purposes)
Journal of Medical Case Reports 2009, 3:7253 http://jmedicalcasereports.com/jmedicalcasereports/article/view/7253
Do you have a case to share?
Submit your case report today
￿ Rapid peer review
￿ Fast publication
￿ PubMed indexing
￿ Inclusion in Cases Database
Any patient, any case, can teach us
something
www.casesnetwork.com